Tulane Home Tulane Shield logo linking to site home page

Tumor Biology & Signaling

Normal cells have a complex series of molecular signals that allow communication between cells as well as transmittal of signals to the cell nucleus. These signals are critical for regulating cell growth, apoptosis, angiogenesis and immune avoidance of the tumor. Changes in the signaling pathways, either through mutation or changes in gene expression, are necessary for tumor growth. These aberrant signaling pathways, both in the tumor and in normal tissues, represent ideal targets for therapeutic intervention in translational cancer research.

Tulane Cancer Center faculty members in the Tumor Biology & Signaling Research Program Include….

Zakaria Abd Elmageed, PhD
Asim Abdel-Mageed, DVM, PhD
Muralidharan Anbalagan, PhD

David Blask, MD, PhD
Matthew Burow, PhD
YiPing Chen, PhD
Douglas Chrisey, PhD

Bridgette Collins-Burow, MD, PhD
David Coy, PhD
Robert Dauchy, MS

Wu-Min Deng, PhD
Yan Dong, PhD
Samir El-Dahr, PhD
David Franklin, PhD
Dahlene Fusco, MD, PhD
Robert Garry, PhD
WT Godbey, PhD

Chang Han, MD, PhD
Steven Hill, PhD – Program Leader
Reza Izadpanah, DVM, PhD
S. Michal Jazwinski, Ph.D.
Jun-yuan Ji, PhD
Donald Krogstad, MD
Muthusamy Kunnimalaiyaan, PhD

Joseph Lasky, M.D.

Chao-Jun Li, PhD
Min Li, MD, PhD
Ming Li, PhD

John McLachlan, PhD
Khalid Matrougui, PhD

Charles Miller, III, PhD
Cindy Morris, PhD
Ken Muneoka, PhD
Kim O'Connor, PhD
Kailash Pandey, PhD
Hee-Won Park, PhD

Brian Rowan, PhD
Oliver Sartor, MD
Suzana Savkovic, PhD
Suresh Sikka, PhD

Deborah Sullivan, PhD
Li-Chun Sun, PhD

Sathihsa Venkateshaiah, PhD
William Wimley, PhD

Tong Wu, MD, PhD
Ihor Yosypiv, MD

Zongbing You, MD, PhD
Haitao Zhang, PhD
Qiuyang Zhang, PhD